About Siriraj Hospital; Division of Hematology, Department of Medicine
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Siriraj Hospital; Division of Hematology, Department of Medicine
During the past decade, Siriraj Hospital; Division of Hematology, Department of Medicine conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 7 clinical trials were completed, i.e. on
average, 700% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia.
2006-12-01
2010-01-01
Completed
560
A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.
2006-12-01
2009-06-01
Completed
573
Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature Babies
2005-05-29
2015-07-17
Completed
800
Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)
2006-02-01
2009-03-01
Completed
75
Study of PF-05212384 (Also Known as PKI-587)Administered Intravenously To Subjects With Solid Tumors
2010-01-01
2012-10-01
Completed
78
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Siriraj Hospital; Division of Hematology, Department of Medicine"
#1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Siriraj Hospital; Division of Hematology, Department of Medicine
According to Clinical.Site data, the most researched conditions in "Siriraj Hospital; Division of Hematology, Department of Medicine" are
"B-cell Lymphoma" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Chronic Myeloid Leukemia" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials) and "Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive" (1 trials). Many other conditions were trialed in "Siriraj Hospital; Division of Hematology, Department of Medicine" in a lesser frequency.
Clinical Trials Intervention Types at Siriraj Hospital; Division of Hematology, Department of Medicine
Most popular intervention types in "Siriraj Hospital; Division of Hematology, Department of Medicine" are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (3 trials), "Rituximab" (3 trials), "CHOP" (2 trials), "Doxorubicin" (2 trials) and "Obinutuzumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Siriraj Hospital; Division of Hematology, Department of Medicine
The vast majority of trials in "Siriraj Hospital; Division of Hematology, Department of Medicine" are
9 trials for "All" genders.
Clinical Trials Status at Siriraj Hospital; Division of Hematology, Department of Medicine
Currently, there are NaN active trials in "Siriraj Hospital; Division of Hematology, Department of Medicine".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Siriraj Hospital; Division of Hematology, Department of Medicine,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Siriraj Hospital; Division of Hematology, Department of Medicine, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".